Literature DB >> 34373544

Psoriasis epidemiology screening tool (PEST) is useful for the detection of psoriatic arthritis in the Japanese population.

Ayako Setoyama1, Yu Sawada2, Natsuko Saito-Sasaki3, Shun Ohmori3, Daisuke Omoto3, Kayo Yamamoto3, Haruna Yoshioka3, Etsuko Okada3, Motonobu Nakamura3.   

Abstract

Psoriasis is a chronic inflammatory skin disease that involves various systemic organs and tissues and is characterized by scaly erythematous skin. Among the different types of psoriasis, psoriatic arthritis (PsA) is frequently reported, and occasionally develops into severe arthritis leading to joint dysfunction. There are various tools, especially questionnaires, to identify the presence of PsA in European and American populations; however, little is known about the utility of these tools in the Asian population. In this study, we investigated the utility of a representative tool, the psoriasis epidemiology screening tool (PEST) questionnaire, to identify PsA among Japanese patients with psoriasis. A total of 143 patients with psoriasis were enrolled in this study. Among them, 29 patients were diagnosed with PsA. The frequency of PsA was significantly increased in patients with PEST scores > 3, with a sensitivity of 93.1% and a specificity of 78.9%. Among the questions in the PEST questionnaire, "Have you ever had a swollen joint?" showed the highest frequency to answer "Yes" among patients with PsA. Univariate and multivariate analyses revealed that high PEST scores (> 3) was an independent variable in PsA patients. Taken together, our study suggests that the PEST questionnaire is a useful tool to identify PsA among Japanese patients with psoriasis.
© 2021. The Author(s).

Entities:  

Year:  2021        PMID: 34373544     DOI: 10.1038/s41598-021-95620-4

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  33 in total

1.  Inflammatory joint manifestations are prevalent in psoriasis: prevalence study of joint and axial involvement in psoriatic patients, and evaluation of a psoriatic and arthritic questionnaire.

Authors:  Gerd-Marie Alenius; Berndt Stenberg; Hans Stenlund; Magnus Lundblad; Solbritt Rantapää Dahlqvist
Journal:  J Rheumatol       Date:  2002-12       Impact factor: 4.666

2.  Clinical characteristics including cardiovascular and metabolic risk factors in adolescents with psoriasis.

Authors:  C Blegvad; A-M Nybo Andersen; J Groot; C Zachariae; J Barker; L Skov
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-02-19       Impact factor: 6.166

3.  Psoriasis Epidemiology Screening Tool (PEST): a report from the GRAPPA 2009 annual meeting.

Authors:  Philip S Helliwell
Journal:  J Rheumatol       Date:  2011-03       Impact factor: 4.666

4.  Japanese guidance for use of biologics for psoriasis (the 2019 version).

Authors:  Hidehisa Saeki; Tadashi Terui; Akimichi Morita; Shigetoshi Sano; Shinichi Imafuku; Akihiko Asahina; Mayumi Komine; Takafumi Etoh; Atsuyuki Igarashi; Hideshi Torii; Masatoshi Abe; Hidemi Nakagawa; Akira Watanabe; Hiroshi Yotsuyanagi; Mamitaro Ohtsuki
Journal:  J Dermatol       Date:  2020-01-08       Impact factor: 4.005

5.  Increased risk of atherosclerotic cardiovascular disease among patients with psoriasis in Korea: A 15-year nationwide population-based cohort study.

Authors:  Keum Ji Jung; Tae-Gyun Kim; Jae Won Lee; Minseok Lee; Jongwook Oh; Sang-Eun Lee; Hyuk-Jae Chang; Sun Ha Jee; Min-Geol Lee
Journal:  J Dermatol       Date:  2019-08-20       Impact factor: 4.005

6.  Psoriasis, fracture risk and bone mineral density: the HUNT Study, Norway.

Authors:  E H Modalsli; B O Åsvold; P R Romundstad; A Langhammer; M Hoff; S Forsmo; L Naldi; M Saunes
Journal:  Br J Dermatol       Date:  2017-03-15       Impact factor: 9.302

7.  Smokers report more psoriasis, but not atopic dermatitis or hand eczema: results from a Norwegian population survey among adults.

Authors:  Kristine Bø; Magne Thoresen; Florence Dalgard
Journal:  Dermatology       Date:  2008       Impact factor: 5.366

8.  Gender difference in disease expression, radiographic damage and disability among patients with psoriatic arthritis.

Authors:  Lihi Eder; Arane Thavaneswaran; Vinod Chandran; Dafna D Gladman
Journal:  Ann Rheum Dis       Date:  2012-05-15       Impact factor: 19.103

9.  The direct cost of care for psoriasis and psoriatic arthritis in the United States.

Authors:  Harold S Javitz; Marcia M Ward; Eugene Farber; Lexie Nail; Susan Gillis Vallow
Journal:  J Am Acad Dermatol       Date:  2002-06       Impact factor: 11.527

Review 10.  Global epidemiology of psoriasis: a systematic review of incidence and prevalence.

Authors:  Rosa Parisi; Deborah P M Symmons; Christopher E M Griffiths; Darren M Ashcroft
Journal:  J Invest Dermatol       Date:  2012-09-27       Impact factor: 8.551

View more
  2 in total

Review 1.  Psoriasis and Systemic Inflammatory Disorders.

Authors:  Tomoko Tashiro; Yu Sawada
Journal:  Int J Mol Sci       Date:  2022-04-18       Impact factor: 6.208

2.  Patient perceptions of psoriatic disease in Japan: Results from the Japanese subgroup of the Understanding Psoriatic Disease Leveraging Insights for Treatment (UPLIFT) survey.

Authors:  Hideshi Torii; Mitsumasa Kishimoto; Masayuki Tanaka; Hidehisa Noguchi; Siddharth Chaudhari
Journal:  J Dermatol       Date:  2022-05-27       Impact factor: 3.468

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.